PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Alexa Fluor® 488 anti-ZAP70 Phospho (Tyr319)/Syk Phospho (Tyr352), 100 tests
Alexa Fluor® 488 anti-ZAP70 Phospho (Tyr319)/Syk Phospho (Tyr352), 25 tests
Alexa Fluor® 488 anti-β-actin, 100 μg
Alexa Fluor® 594 anti-Alix, 100 μg
Alexa Fluor® 594 anti-Chk2, 25 μg
Alexa Fluor® 594 anti-Cytokeratin (pan reactive), 100 μg
Alexa Fluor® 594 anti-Cytokeratin 18, 100 μg
Alexa Fluor® 594 anti-Cytokeratin 19, 100 μg
Alexa Fluor® 594 anti-E1 Ubiquitin Activating Enzyme, 100 μg
Alexa Fluor® 594 anti-eIF4E, 25 μg
Alexa Fluor® 594 anti-ERK1/2, 25 μg
Alexa Fluor® 594 anti-GFAP, 100 μg
Alexa Fluor® 594 anti-H2A.X Phospho (Ser139), 100 μg
Alexa Fluor® 594 anti-HDAC3, 25 μg
Alexa Fluor® 594 anti-HMGB1, 100 μg
Alexa Fluor® 594 anti-IGF2BP2, 100 μg